Skip to main content

Table 1 Expression levels of 13 features regarding 9 immune checkpoint markers in nasopharyngeal carcinoma

From: Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

No. of NPC Patients (%) with Expression Above the Cutoff Value
MarkerMedian>  1%>  5%>  25%>  50%
TAIC expression
 PD-L112.97201 (97)151 (73)59 (28)16 (8)
 B7-H326.13196 (94)175 (84)105 (50)50 (24)
 B7-H422.06205 (99)195 (94)90 (43)21 (10)
 IDO-120.75206 (99)187 (90)83 (40)14 (7)
 LAG35.55197 (95)109 (52)15 (7)5 (2)
 VISTA12.46205 (99)169 (81)30 (14)3 (1)
 TIM32.75183 (88)62 (30)0 (0)0 (0)
 ICOS26.21207 (100)204 (98)111 (53)9 (4)
 OX4019.95208 (100)192 (92)80 (38)24 (12)
TC expression
 PD-L110.44191 (92)136 (65)49 (24)22 (11)
 B7-H37.01165 (79)115 (55)50 (24)19 (9)
 B7-H413.41200 (96)162 (78)57 (27)13 (6)
 IDO-17.66195 (94)131 (63)23 (11)6 (3)
  1. Abbreviations: TC tumour cell, TAIC tumour-associated immune cell